CBM Pathology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CBM Pathology - overview
Established
1999
Location
Gaithersburg, MD, US
Primary Industry
Healthcare Specialists
About
CBM Pathology provides specialized pathology and esoteric testing services, collaborating with CBLPath and GPA Laboratories to enhance diagnostic capabilities for healthcare providers. CBM Pathology, founded in 1999, operates in Gaithersburg, US, delivering comprehensive pathology services. The company was acquired by Aurora Diagnostics, LLC in December 2017. The founder's background includes experience in the diagnostics industry, although specific details are not available.
CBM Pathology specializes in high-quality pathology and esoteric testing services through strategic partnerships with CBLPath and GPA Laboratories. Their offerings include an expanded in-house test menu featuring advanced molecular testing tailored to the needs of clinical practices. Their services are primarily directed toward healthcare providers across regions such as New York and North Carolina, utilizing state-of-the-art laboratory facilities and a skilled team of pathologists. The client base consists of hospitals, outpatient clinics, and private practices, ensuring timely and accurate diagnostic results for patients.
CBM Pathology's revenue model is built on B2B relationships with healthcare providers who rely on their laboratory services. The company engages in direct service agreements, offering bespoke testing solutions that cater to individual client requirements. Pricing is competitive and designed to accommodate various budgets, including self-pay options and financial assistance programs. The partnership with CBLPath and GPA Laboratories broadens their service offerings, enhancing revenue opportunities and supporting sustained growth in the healthcare sector.
CBM Pathology aims to develop new products and expand its testing capabilities to meet increasing demands in the healthcare sector. The company plans to target new geographic regions for expansion, although specific markets have not been disclosed. The acquisition by Aurora Diagnostics, LLC in December 2017 is expected to provide strategic resources to support these initiatives.
Current Investors
Aurora Diagnostics, LLC
Primary Industry
Healthcare Specialists
Sub Industries
Mental Health Services
Website
http://cbmpath.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
CBM Pathology - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | CBM Pathology | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.